Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study With Cisplatinum and Conventional or Adaptive High Dose Radiotherapy for Advanced Head and Neck Cancer

NCT01504815 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT01504815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01504815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study With Cisplatinum and Conventional or Adaptive High Dose Radiotherapy for Advanced Head and Neck Cancer
Lead sponsor
The Netherlands Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
September 7, 2012
Completion date
December 24, 2024
Enrollment
268 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer